PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsPar Pharmaceutical
Par Pharmaceutical(PRX)
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AmiodaroneAmiodarone2003-04-252029
AmitriptylineAmitriptyline1984-09-25
AntizolFomepizole1997-12-042027
BrompheniramineBrompheniramine1982-01-01
ChlorpropamideChlorpropamide1984-02-27
ClonidineClonidine1986-07-082027-2031
Clonidine chlorthalidoneChlorthalidone, Clonidine1987-12-162027-2031
1
2
3
4
5
6
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Doxycycline hyclate
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use